Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals(NASDAQ:RXRX) and Schrödinger(NASDAQ:SDGR) depends on ...

With an upside potential of 99.1% and a relative strength index (RSI) of 33.8, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands out as one of the notable oversold play in the AI sector. While ...

Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter profiling. The first full beta of Python 3.15 ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Apps that record visits are becoming popular, but they come with privacy and accuracy concerns. By Simar Bajaj At your next appointment, your doctor may have a new kind of assistant listening in: ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

If you’ve ever left a meeting with a vague memory of what was discussed and a page full of half-baked, poorly-written notes, Google just built something for you. At Google Cloud Next 2026 in Las Vegas ...

U.S. Supreme Court Justice Clarence Thomas on Wednesday praised the University of Texas as a national leader for its work to restore civic values and more closely focus on the study of Western ...

Last week, while listening to the oral argument in Trump v. Barbara, I was pleasantly surprised to hear Justice Gorsuch ask the Solicitor General and Cecilia Wang, counsel for the ACLU, about Justice ...